Telix Completes Acquisition Of Next-Generation Therapeutic Assets And Innovative Biologics Technology Platform
Pursuant to the transaction with Telix, ImaginAb has retained its lead imaging candidate, CD8 ImmunoPET, which is currently in Phase 2 clinical trials and has been licensed by numerous pharmaceutical ...
TMCnet57m
ARNC Investors Have Opportunity to Lead Arconic Corporation Securities Fraud Lawsuit with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Arconic Corporation ("Arconic" or "the Company") (ARNC) for violations of §§10 ...